Idiopathic Pulmonary Fibrosis Clinical Trial
— TURK-UIPOfficial title:
Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study
| NCT number | NCT02821039 |
| Other study ID # | TTS-01 |
| Secondary ID | |
| Status | Terminated |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 2016 |
| Est. completion date | July 8, 2019 |
| Verified date | September 2019 |
| Source | Turkish Thoracic Society |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational [Patient Registry] |
The Turkish Thoracic Society Usual Interstitial Pneumonia Registry (TURK-UIP) is a collaborative project to coordinate a team of investigators from various regions of Turkey. The purpose of the Registry is to collect epidemiological data on patients with idiopathic pulmonary fibrosis and other causes of UIP, and to obtain information about the natural course of the disease and the treatment response.
| Status | Terminated |
| Enrollment | 1678 |
| Est. completion date | July 8, 2019 |
| Est. primary completion date | July 8, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: 1. Understand and sign the informed consent document. 2. The presence of a definite or possible UIP pattern on high resolution computed tomography (HRCT) or a histologic UIP pattern (definite, probable and possible) on surgical lung biopsy (as defined by ATS/ERS/JRS/ALAT criteria). Exclusion Criteria: 1. HRCT findings inconsistent with UIP pattern (peribronchovascular predominance, extensive ground glass abnormality,profuse micronodules, discrete cysts , consolidation in bronchopulmonary segment(s)/lobe(s), diffuse mosaic attenuation/air-trapping), 2. Histopathological findings inconsistent with UIP pattern (as defined by ATS/ERS/JRS/ALAT criteria). |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Cukurova University Medical Faculty | Adana | |
| Turkey | Sakarya University Faculty of Medicine | Adapazari | |
| Turkey | Ankara University Faculty of Medicine | Ankara | |
| Turkey | Ankara University Medical Faculty | Ankara | |
| Turkey | Atatürk Chest Disease and Chest Surgery Research and Training Hospital | Ankara | |
| Turkey | Ataturk Chest Diseases and Chest Surgery Education and Research Hospital | Ankara | |
| Turkey | Diskapi Yildirim Beyazit Training and Research Hospital | Ankara | |
| Turkey | Gazi University Medical Faculty | Ankara | |
| Turkey | Gazi University Medical Faculty | Ankara | |
| Turkey | Akdeniz University Medical Faculty | Antalya | |
| Turkey | Adnan Menderes University Faculty of Medicine | Aydin | |
| Turkey | Uludag University Medical Faculty | Bursa | |
| Turkey | Pamukkale University Medical Faculty | Denizli | |
| Turkey | Dicle University Medical Faculty | Diyarbakir | |
| Turkey | Memorial Diyarbakir Hospital | Diyarbakir | |
| Turkey | Duzce University Medical Faculty | Duzce | |
| Turkey | Trakya University Faculty of Medicine | Edirne | |
| Turkey | Atatürk University Faculty of Medicine | Erzurum | |
| Turkey | Atatürk University Medical Faculty | Erzurum | |
| Turkey | Dr.Lutfi Kirdar Kartal Education and Research Hospital | Istanbul | |
| Turkey | Istanbul University Cerrahpasa Medical Faculty | Istanbul | |
| Turkey | Istanbul University Istanbul Medical Faculty | Istanbul | |
| Turkey | Istanbul University, Istanbul Medical Faculty | Istanbul | |
| Turkey | Koç University Medical Faculty | Istanbul | |
| Turkey | Sisli Florence Nightingale Hospital | Istanbul | |
| Turkey | Sureyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital | Istanbul | |
| Turkey | Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital | Istanbul | |
| Turkey | Süreyyapasa Pulmonary Diseases and Thoracic Surgery Education and Research Hospital | Istanbul | |
| Turkey | Yedikule Chest Disease Education and Research Hospital | Istanbul | |
| Turkey | Yedikule Chest Diseases and Chest Surgery Education and Research Hospital | Istanbul | |
| Turkey | Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital | Istanbul | |
| Turkey | Yedikule Chest Diseases Education and Research Hospital | Istanbul | |
| Turkey | Yedikule Hospital for Chest Disease and Chest Surgery | Istanbul | |
| Turkey | Yedikule Hospital for Chest Disease and Thoracic Surgery | Istanbul | |
| Turkey | Yedikule Pulmonary Diseases Education and Research Hospital | Istanbul | |
| Turkey | Dokuz Eylul University Medical Faculty | Izmir | |
| Turkey | Dr. Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital | Izmir | |
| Turkey | Dr. Suat Seren Pulmonary Diseases and Thoracic Surgery Training and Research Hospital | Izmir | |
| Turkey | Ege University Faculty of Medicine | Izmir | |
| Turkey | Ege University Medical Faculty | Izmir | |
| Turkey | Kirikkale University Medical Faculty | Kirikkale | |
| Turkey | Kocaeli University Faculty of Medicine | Kocaeli | |
| Turkey | Kocaeli University Medical Faculty | Kocaeli | |
| Turkey | Necmettin Erbakan University Meram Medical Faculty | Konya | |
| Turkey | Ondokuz Mayis University Medical Faculty | Samsun | |
| Turkey | Karadeniz Technical University Medical Faculty | Trabzon |
| Lead Sponsor | Collaborator |
|---|---|
| Turkish Thoracic Society |
Turkey,
American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304. Review. Erratum in: Am J Respir Crit Care Med2002 Aug 1;166(3):426. — View Citation
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL. — View Citation
Ryerson CJ, Corte TJ, Collard HR, Richeldi L. A global registry for idiopathic pulmonary fibrosis: the time is now. Eur Respir J. 2014 Aug;44(2):273-6. doi: 10.1183/09031936.00051914. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of subjects enrolled with IPF and other causes of UIP | Natural history of course of disease in patients with IPF and other causes of UIP. | 5 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05984992 -
The First-in-human Study of SRN-001 in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT04312594 -
Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
| Recruiting |
NCT03865927 -
GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
| Completed |
NCT03979430 -
Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study
|
N/A | |
| Enrolling by invitation |
NCT04905693 -
Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
|
Phase 3 | |
| Not yet recruiting |
NCT06241560 -
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
|
Phase 2 | |
| Terminated |
NCT04419558 -
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
|
Phase 3 | |
| Completed |
NCT03725852 -
A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)
|
Phase 2 | |
| Terminated |
NCT03573505 -
An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
| Recruiting |
NCT04148157 -
Quality of Life in IPF - Patient and Physician Perceptions
|
||
| Completed |
NCT03222648 -
Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis
|
N/A | |
| Not yet recruiting |
NCT06422884 -
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
|
Phase 2 | |
| Completed |
NCT02257177 -
RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT02268981 -
Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)
|
N/A | |
| Withdrawn |
NCT01524068 -
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
|
Phase 2 | |
| Enrolling by invitation |
NCT01382368 -
Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients
|
Phase 4 | |
| Completed |
NCT01110694 -
Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study
|
||
| Completed |
NCT01199887 -
Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis
|
Phase 1 | |
| Active, not recruiting |
NCT02951416 -
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
|
||
| Terminated |
NCT00981747 -
Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
|
Phase 2/Phase 3 |